Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development is a research paper published in PLoS ONE (2025). On theSindex it has a DataRank of 0.354. It has been cited 8 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.0243
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
DAIDS
Grant: UM1AI068633
DAIDS
Grant: UM1AI068615
DAIDS
Grant: UM1AI106707
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Grant: HHSN275201200002I
National Institutes of Health
Grant: 5UM1AI106707-04
Laboratory Center (LC): Microbicide Trials Network
National Institutes of Health
Grant: 4UM1AI068633-15
Leadership and Operations Center (LOC): Microbicide Trials Network
National Institutes of Health
Grant: 5UM1AI068615-12
Statistical and Data Management Center (SDMC): Microbicide Trials Network
NICHD NIH HHS
Grant: HHSN275201200002C
NIAID NIH HHS
Grant: UM1 AI068617
FWCI
6.21
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals